Full year new awards of $8.8 billion ; ending backlog $18.9 billion Year-end cash and marketable securities balance of $2.3 billion 2021 cost optimization program resulted in run-rate savings to date of $52 million 2022 adjusted earnings per share (EPS) guidance established at a range of $1.15 to
Related Post
